• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Association between the COVID-19 pandemic and cardiopulmonary function in acute coronary syndrome patients without SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Aug 22;15(1):30906.
doi: 10.1038/s41598-025-17016-y. Association between the COVID-19 pandemic and cardiopulmonary function in acute coronary syndrome patients without SARS-CoV-2 infection

Xingbo Mu[SUP] 1 2 [/SUP], Sicheng Ning[SUP] 1 2 [/SUP], Quanyu Zhang[SUP] 1 [/SUP], Yi Zhang[SUP] 1 [/SUP], Shengyi Wang[SUP] 1 [/SUP], Jian Zhang[SUP] 1 [/SUP], Yanchun Liang[SUP] 1 [/SUP], Yaling Han[SUP] 3 [/SUP]



Affiliations
Abstract

The COVID-19 pandemic disrupted cardiovascular disease management. This single-center cross-sectional cohort study evaluated cardiopulmonary function changes in acute coronary syndrome (ACS) patients post-percutaneous coronary intervention (PCI) without SARS-CoV-2 infection and explored pandemic-related influencing factors. We analyzed 7,650 ACS patients undergoing complete PCI revascularization and cardiopulmonary exercise testing (CPET) between October 2018 and December 2023, stratified into pre-pandemic (cut-off: February 1, 2020), during-pandemic, and post-pandemic (cut-off: December 31, 2022) groups. Propensity Score Matching (PSM) balanced baseline characteristics, yielding 4,503 patients for analysis. Clinical/laboratory data and CPET results were compared across groups using one-way analysis of variance (ANOVA). The primary CPET parameter, peak oxygen uptake per kilogram (peak VO₂/kg), was significantly lower in the during-pandemic group (15.07 ± 4.09 ml/min/kg) compared to the pre-pandemic group (15.56 ± 3.74 ml/min/kg) and the post-pandemic group (15.69 ± 4.04 ml/min/kg). Machine learning and multivariate logistic regression were used to select key variables related to cardiopulmonary function. The findings indicate that older age, female sex, higher BMI, elevated SYNTAX score, increased NT-pro BNP levels, elevated HbA1c, smoking, anxiety, and higher ACS severity classification were positively correlated with impaired cardiopulmonary function. These results highlight associations between the pandemic and cardiovascular rehabilitation outcomes, emphasizing the need for tailored interventions during healthcare crises.

Keywords: Acute coronary syndrome; COVID-19; Cardiac rehabilitation; Cardiopulmonary exercise testing.

 
Back
Top Bottom